Immunohistochemistry (IHC) Market - Trends Forecast Till 2028

Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End user (Hospitals, Diangostic labs, Academia), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-PH-IHCM-475

Format:  

Number of Pages: 376

Domain: Pharmaceutical

Immunohistochemistry (IHC) Market – Trends Forecast Till 2028

The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2028.

A laboratory method that uses antibodies to check for certain antigens (markers) in a sample of tissue. The antibodies are usually linked to an enzyme or a fluorescent dye. IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs).

The rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests are some of the factors that have supported long-term expansion for Immunohistochemistry (IHC) Market.

Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Within a few weeks of research, companies started coming up with drugs and treatments to treat the infection. There has been a tremendous amount of effort put into developing new treatments and vaccines to cure the infection.

Immunohistochemistry (IHC) Market Analysis

North America was the largest regional market for immunohistochemistry market in 2020. APAC is expected to register the fastest growth rate during the forecast period owing to several factors, including increasing disposable income, rising healthcare spending, growing demand for quality medical care, and increasing investments by pharmaceutical and biopharmaceutical companies.

Immunohistochemistry (IHC) Market is segmented into product, application, end user and region.

On the basis of Product

  • Antibodies
  • Reagents
  • Equipment
  • kits

On the basis of Application

  • diagnostic applications
  • research applications
  • forensic applications

On the basis of End-User

  • Hospitals & Diagnostic Laboratories
  • Academic & research Institutes
  • Other end users (CROs, pharma & biopharma companies, and forensic laboratories)

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Immunohistochemistry (IHC) Market Primary respondent

 

Key Players

  • F. Hoffman-La Roche AG
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Abcam plc
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • PHC Holdings Corporation
  • Cell Signaling Technology, Inc.
  • Bio SB, Inc.
  • Miltenyi Biotec
  • CANDOR Bioscience GmbH
  • Sakura Finetek Japan Co., Ltd.
  • Eagle Biosciences, Inc.
  • Biocare Medical, LLC
  • Elabscience, Inc.
  • Biogenex Laboratories
  • Diagnostic Biosystems, Inc.
  • BioVision Inc.
  • Rockland Immunochemicals, Inc.
  • Genemed Biotechnologies, Inc.

Recent Developments

  • In August 2021, Roche received FDA approval for VENTANA MMR RxDx companion diagnostic test based on immunohistochemistry for solid tumors that are deficient in the MMR pathway. The test identifies patients eligible for GSK’s anti-PD1 immunotherapy, JEMPERLI.
  • In August 2021, Agilent received a CE-IVD mark in Europe for its PD-L1 IHC 22C3 pharmDx assay for the identification of oesophageal cancer patients for treatment with KEYTRUDA.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Immunohistochemistry (IHC) Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 2.3 billion

Growth Rate

CAGR of 7.7% during the forecasting period, 2021-2026

Historical Data

2018-2019

Forecast Years

2021-2026

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2026

Report Segmentation

product, application, end user and region

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

F. Hoffman-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Abcam plc, Becton, Dickinson and Company, PerkinElmer, Inc., Takara Bio, Inc., Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Cell Signaling Technology, Inc., Bio SB, Inc., Miltenyi Biotec, CANDOR Bioscience GmbH, Sakura FinetEK, Japan Co., Ltd., Eagle Biosciences, Inc., BioCare Medical, LLC, Elabscience, Inc., Biogenex Laboratories, Diagnostic Biosystems, Inc., BioVision Inc., Rockland Immunochemicals, Inc., Biotechnologies, Inc.

Available Customization

In addition to the market data for Immunohistochemistry (IHC) Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.